KITLG and cancer: Cancer cells release inflammatory mediators as well as pro-angiogenic factors, including fibroblast growth factor 2 (FGF-2), SCF, and nerve growth factor (NGF), thus activating vascular epithermal growth factor (VEGF) and SCF/c-KIT signaling among others.